tolvaptan has been researched along with Edema in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (76.19) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Bagga, A; Hari, P; Meena, J; Sinha, A | 1 |
| Hirano, T; Kim, S; Kinugawa, K; Nakata, E | 1 |
| Abe, H; Arai, T; Atsukawa, M; Chuma, M; Fukunishi, S; Hattori, N; Hiraoka, A; Iio, E; Ikegami, T; Itokawa, N; Iwakiri, K; Iwasa, M; Kato, K; Kondo, C; Kumada, T; Michitaka, K; Nakagawa-Iwashita, A; Nozaki, A; Okubo, H; Okubo, T; Senoh, T; Tada, T; Takaguchi, K; Takei, Y; Tanaka, Y; Tani, J; Toyoda, H; Tsubota, A; Tsutsui, A; Uojima, H; Watanabe, T; Yokohama, K; Yoshida, Y | 1 |
| Fukuta, Y; Hirano, T; Kurosaki, M; Okada, M; Sakaida, I; Terai, S | 1 |
| Kaku, Y; Nishimura, M; Saimiya, M | 1 |
| Hiramatsu, A; Hiramine, Y; Iwamoto, T; Izumi, N; Kawaratani, H; Kimura, M; Koike, K; Nakanishi, H; Okita, K; Sakaida, I; Terai, S; Uojima, H; Uto, H; Yoshiji, H | 1 |
| Isaka, Y; Iwatani, H; Kawabata, H; Nagai, N; Shirahase, K; Yamamichi, Y | 1 |
| Akimoto, T; Kobayashi, T; Maeshima, A; Masuda, T; Matsuoka, R; Murakami, T; Muto, S; Nagata, D; Nagayama, I; Nakagawa, S; Ohara, K; Saito, O | 1 |
| Ando, H; Fukada, H; Kanazawa, R; Kokubu, S; Miyazaki, A; Nakadera, E; Okubo, H; Sagawa, E; Sorin, Y | 1 |
| Kobayashi, T; Komatsu, M; Komorizono, Y; Okada, M; Okita, K; Sakai, T; Sakaida, I; Yamashita, S | 1 |
| Ishikawa, S; Iwasaki, H; Kuroda, M; Muraoka, M; Ohta, K; Shimizu, M; Tasaki, Y; Yachi, Y; Yachie, A | 1 |
| Bockenhauer, D | 1 |
| Sakaida, I | 1 |
| Ding, HG; Dong, PL; Fan, CL; Li, B; Li, L; Li, P; Wang, SZ; Zhang, X; Zhao, WM; Zheng, JF | 1 |
| Huh, YS; Kim, GH; Park, ES | 1 |
| Arai, T; Atsukawa, M; Itokawa, N; Iwakiri, K; Kondo, C; Nakagawa, A; Narahara, Y; Okubo, T; Tsubota, A | 1 |
| Nakamura, T; Node, K; Sato, E; Tanaka, A; Ueda, Y | 1 |
| Evans, H; Gilbert, RD; Griffiths, M; Haq, MR; Nagra, A; Olalekan, K | 1 |
| Chayama, K; Kaneko, A; Kato, M; Murawaki, Y; Okada, M; Okita, K; Ono, N; Sakaida, I; Sata, M; Yoshihara, H; Yoshihara, N | 1 |
| Fujiki, H; Miyazaki, T; Ohmoto, K; Sakamoto, Y; Yamashita, T | 1 |
| Inui, Y; Kakiuchi, S; Kawamori-Iwamoto, Y; Kurata, K; Matsuoka, H; Minami, H; Miyata, Y; Murayama, T; Okamura, A; Sanada, Y; Tomioka, H; Yakushijin, K; Yamamoto, K | 1 |
1 review(s) available for tolvaptan and Edema
| Article | Year |
|---|---|
Tolvaptan for the treatment of liver cirrhosis oedema.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Edema; Humans; Liver Cirrhosis; Tolvaptan; Treatment Outcome | 2014 |
2 trial(s) available for tolvaptan and Edema
| Article | Year |
|---|---|
Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema.
Topics: Aged; Ascites; Benzazepines; Body Weight; Diuretics; Drug Administration Schedule; Edema; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Protective Agents; Sodium; Tolvaptan; Treatment Outcome | 2013 |
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Dose-Response Relationship, Drug; Edema; Female; Furosemide; Humans; Japan; Liver Cirrhosis; Lower Extremity; Male; Middle Aged; Tolvaptan; Treatment Outcome; Waist Circumference | 2010 |
18 other study(ies) available for tolvaptan and Edema
| Article | Year |
|---|---|
Efficacy and Safety of Combination Therapy with Tolvaptan and Furosemide in Children with Nephrotic Syndrome and Refractory Edema: A Prospective Interventional Study.
Topics: Child; Child, Preschool; Diuretics; Drug Therapy, Combination; Edema; Furosemide; Heart Failure; Humans; Male; Nephrotic Syndrome; Prospective Studies; Tolvaptan | 2022 |
Tolerability of the Intravenously Administered Tolvaptan Prodrug, OPC-61815, in Patients With Congestive Heart Failure Who Have Difficulty With, or Are Incapable of, Oral Intake (TRITON-HF) - A Phase III, Multicenter, Open-Label Trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Dyspnea; Edema; Heart Failure; Humans; Prodrugs; Tolvaptan | 2022 |
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Drug Therapy, Combination; Edema; Female; Furosemide; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Prognosis; Retrospective Studies; ROC Curve; Spironolactone; Survival Rate; Time Factors; Tolvaptan | 2020 |
Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study).
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Blood Urea Nitrogen; Edema; Female; Humans; Japan; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Tolvaptan; Treatment Outcome | 2020 |
Efficacy of oral tolvaptan for severe edema and hyponatremia in a patient with refractory nephrotic syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Child; Edema; Humans; Hyponatremia; Male; Nephrotic Syndrome; Tolvaptan | 2021 |
Response criteria of tolvaptan for the treatment of hepatic edema.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Dose-Response Relationship, Drug; Edema; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; ROC Curve; Severity of Illness Index; Tolvaptan; Treatment Outcome; Weight Loss; Young Adult | 2018 |
Tolvaptan Efficiently Reduces Intracellular Fluid: Working Toward a Potential Treatment Option for Cellular Edema.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Diuretics; Edema; Electric Impedance; Female; Humans; Intracellular Fluid; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Tolvaptan | 2019 |
Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; Edema; Fluid Shifts; Furosemide; Humans; Leg; Liver Cirrhosis; Male; Renal Insufficiency, Chronic; Tolvaptan | 2019 |
Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Edema; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Serum Albumin; Tolvaptan; Treatment Outcome | 2019 |
Tolvaptan therapy for massive edema in a patient with nephrotic syndrome.
Topics: Anti-Inflammatory Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Edema; Female; Humans; Nephrotic Syndrome; Prednisolone; Renal Dialysis; Tolvaptan; Urodynamics | 2014 |
Draining the edema: a new role for aquaretics?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diabetes Insipidus, Neurogenic; Edema; Female; Humans; Male; Nephrotic Syndrome; Tolvaptan | 2014 |
Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Biomarkers; Edema; Female; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Sodium; Time Factors; Tolvaptan; Treatment Outcome; Urination; Urodynamics | 2014 |
Is tolvaptan indicated for refractory oedema in nephrotic syndrome?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Edema; Humans; Kidney; Male; Middle Aged; Natriuresis; Nephrosis, Lipoid; Sodium; Steroids; Time Factors; Tolvaptan; Treatment Outcome | 2015 |
Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Edema; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Patient Selection; Portal Pressure; Predictive Value of Tests; Prospective Studies; Time Factors; Tolvaptan; Treatment Outcome; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 2016 |
Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Edema; Female; Glomerulonephritis, Membranous; Humans; Middle Aged; Nephrotic Syndrome; Tolvaptan | 2017 |
Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease.
Topics: Benzazepines; Edema; Female; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidney Function Tests; Parenteral Nutrition; Polycystic Kidney, Autosomal Dominant; Pregnancy; Receptors, Vasopressin; Tolvaptan; Treatment Outcome; TRPP Cation Channels; Young Adult | 2017 |
Anti-edematous effects of tolvaptan in experimental rodent models.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Carrageenan; Disease Models, Animal; Diuretics; Edema; Foot Diseases; Histamine; Male; Permeability; Rats; Rats, Sprague-Dawley; Skin Diseases, Vascular; Sodium; Tolvaptan | 2011 |
Tolvaptan as an alternative treatment for refractory fluid retention associated with sinusoidal obstruction syndrome after allogeneic stem cell transplantation.
Topics: Adult; Benzazepines; Edema; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Tolvaptan; Transplantation, Homologous | 2013 |